Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Cue Biopharma (CUE): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
7 analysts
Options Flow (P/C)
—
Avg Consensus PT
$4
-84.4%
Highest Price Target
$10
-64.7%
Lowest Price Target
$2
-92.9%
Short Interest
4.7%
Declining — Bullish
Insider Activity (30d)
Neutral
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 25, 2025 | LUCID CAPITAL MARKETS | Dev Prasad — | -85.9% | $4 | Initiate | Buy |
| Apr 2, 2025 | Citizens Capital Markets | Reni Benjamin— | -92.9% | $2 → $2 | Maintained | Market Outperform |